PFA Pension Forsikringsaktieselskab Invests $43.39 Million in GE HealthCare Technologies Inc. $GEHC

PFA Pension Forsikringsaktieselskab acquired a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 520,754 shares of the company’s stock, valued at approximately $43,394,000.

Several other institutional investors have also recently modified their holdings of GEHC. E Fund Management Hong Kong Co. Ltd. raised its stake in shares of GE HealthCare Technologies by 130.7% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after purchasing an additional 196 shares during the last quarter. Godsey & Gibb Inc. purchased a new position in shares of GE HealthCare Technologies in the third quarter worth about $26,000. Laurel Wealth Advisors LLC acquired a new stake in GE HealthCare Technologies in the fourth quarter valued at approximately $26,000. Optima Capital LLC acquired a new stake in GE HealthCare Technologies in the fourth quarter valued at approximately $27,000. Finally, Maseco LLP acquired a new stake in GE HealthCare Technologies in the fourth quarter valued at approximately $29,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $61.03 on Friday. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77. The company has a quick ratio of 1.13, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The company has a market capitalization of $27.76 billion, a P/E ratio of 14.60, a P/E/G ratio of 1.39 and a beta of 0.75. The stock’s fifty day moving average is $73.28 and its two-hundred day moving average is $77.56.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. During the same quarter in the prior year, the firm earned $1.01 EPS. GE HealthCare Technologies’s revenue for the quarter was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Equities analysts expect that GE HealthCare Technologies Inc. will post 4.88 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is currently 3.35%.

Analysts Set New Price Targets

Several analysts have commented on GEHC shares. Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, March 21st. Evercore set a $80.00 price objective on GE HealthCare Technologies in a report on Thursday. Wells Fargo & Company dropped their price objective on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a report on Thursday. Barclays dropped their price objective on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a report on Thursday. Finally, Morgan Stanley raised their price objective on GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Wednesday, February 4th. Eight analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $80.67.

Insider Activity at GE HealthCare Technologies

In other news, CEO Peter J. Arduini acquired 4,169 shares of the business’s stock in a transaction that occurred on Thursday, April 30th. The shares were purchased at an average price of $59.92 per share, for a total transaction of $249,806.48. Following the acquisition, the chief executive officer owned 259,424 shares of the company’s stock, valued at $15,544,686.08. This represents a 1.63% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO James Saccaro acquired 3,310 shares of the business’s stock in a transaction that occurred on Friday, May 1st. The stock was purchased at an average price of $60.60 per share, for a total transaction of $200,586.00. Following the acquisition, the chief financial officer directly owned 87,471 shares in the company, valued at approximately $5,300,742.60. This trade represents a 3.93% increase in their position. The SEC filing for this purchase provides additional information. In the last 90 days, insiders have bought 9,229 shares of company stock worth $556,180. 0.36% of the stock is currently owned by company insiders.

Key Headlines Impacting GE HealthCare Technologies

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Insiders are buying shares — CEO Peter Arduini, CFO James Saccaro and director Frank R. Jimenez increased positions (multiple Form 4 filings), which investors often interpret as management confidence in the company’s outlook. Read More. • Read More. • Read More.
• Positive Sentiment: Heavy call-option buying — an unusual surge in call volume suggests short-term bullish/speculative interest that can amplify upside moves. (No article link available)
• Neutral Sentiment: Wells Fargo lowered its price target to $75 but kept an overweight rating, signaling upside exists vs. current levels while tempering near-term expectations. Read More.
• Neutral Sentiment: Operational changes — GEHC announced a reorganization (Imaging + Advanced Visualization) and executive moves intended to improve execution; benefits could take multiple quarters to materialize. Read More.
• Negative Sentiment: Guidance cut and margin pressure — management trimmed FY26 EPS guidance to $4.80–5.00, citing inflation, higher component and freight costs and supply issues; this is the core reason for recent downside pressure. Read More.
• Negative Sentiment: Mixed Q1 results — revenue beat (~$5.13B) but EPS missed ($0.99 vs. $1.07 est.) and margins compressed, reinforcing short‑term risk to earnings. Read More.
• Negative Sentiment: Analyst downgrades / price‑target cuts — Citigroup, JPMorgan and others trimmed targets and ratings (e.g., PTs cut to ~$65–75), pulling sell‑side support lower and contributing to volatility. Read More.
• Negative Sentiment: Investor litigation inquiry — a Johnson Fistel investigation adds headline and legal risk that could increase volatility. Read More.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.